Lineage Cell Therapeutics Inc (LCTX) — Tangible Net Worth Ratio
Lineage Cell Therapeutics Inc (LCTX) has a Tangible Net Worth Ratio of -52.4% as of September 2025. This metric is calculated by deducting intangible assets ($31.70 Million) from net assets ($20.80 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See Lineage Cell Therapeutics Inc (LCTX) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Lineage Cell Therapeutics Inc Tangible Net Worth Ratio (1991–2024)
This chart shows how Lineage Cell Therapeutics Inc's Tangible Net Worth Ratio has changed across 27 annual periods from 1991 to 2024. As of September 2025, the ratio stands at -52.4%, reflecting net assets of $20.80 Million with intangible assets of $31.70 Million USD. See LCTX days of operational coverage to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Lineage Cell Therapeutics Inc (1991–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Lineage Cell Therapeutics Inc from 1991 to 2024, covering 27 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Lineage Cell Therapeutics Inc market capitalisation.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 39.6% | $77.01 Million | $46.54 Million | $113.22 Million | ▲ +14.6 pp |
| 2023 | 24.9% | $62.02 Million | $46.56 Million | $101.02 Million | ▼ -10.2 pp |
| 2022 | 35.1% | $71.94 Million | $46.69 Million | $123.66 Million | ▼ -13.4 pp |
| 2021 | 48.5% | $90.90 Million | $46.82 Million | $174.54 Million | ▼ -2.1 pp |
| 2020 | 50.6% | $95.13 Million | $47.03 Million | $107.95 Million | ▼ -6.1 pp |
| 2019 | 56.6% | $111.25 Million | $48.25 Million | $125.48 Million | ▼ -40.0 pp |
| 2018 | 96.6% | $92.25 Million | $3.12 Million | $101.66 Million | ▲ +0.8 pp |
| 2017 | 95.8% | $164.26 Million | $6.90 Million | $173.24 Million | ▲ +3.6 pp |
| 2016 | 92.2% | $130.51 Million | $10.21 Million | $142.57 Million | ▲ +36.1 pp |
| 2015 | 56.1% | $76.45 Million | $33.59 Million | $94.66 Million | ▲ +18.0 pp |
| 2014 | 38.1% | $62.72 Million | $38.85 Million | $74.90 Million | ▲ +47.4 pp |
| 2013 | -9.3% | $42.26 Million | $46.21 Million | $57.73 Million | ▼ -25.0 pp |
| 2012 | 15.7% | $24.29 Million | $20.49 Million | $29.75 Million | ▼ -39.4 pp |
| 2011 | 55.1% | $41.46 Million | $18.62 Million | $45.83 Million | ▼ -13.8 pp |
| 2010 | 68.9% | $49.43 Million | $15.39 Million | $53.27 Million | ▼ -31.1 pp |
| 2009 | 100.0% | $11.05 Million | $0.00 | $13.43 Million | ▲ +0.0 pp |
| 2004 | 100.0% | $344.77K | $0.00 | $1.52 Million | ▲ +0.0 pp |
| 2000 | 100.0% | $1.32 Million | $0.00 | $1.68 Million | ▲ +0.0 pp |
| 1999 | 100.0% | $5.08 Million | $0.00 | $5.68 Million | ▲ +0.0 pp |
| 1998 | 100.0% | $2.40 Million | $0.00 | $2.80 Million | ▲ +0.0 pp |
| 1997 | 100.0% | $6.50 Million | $0.00 | $8.30 Million | ▲ +0.0 pp |
| 1996 | 100.0% | $2.80 Million | $0.00 | $3.00 Million | ▲ +0.0 pp |
| 1995 | 100.0% | $2.80 Million | $0.00 | $3.00 Million | ▲ +0.0 pp |
| 1994 | 100.0% | $3.20 Million | $0.00 | $3.60 Million | ▲ +0.0 pp |
| 1993 | 100.0% | $5.80 Million | $0.00 | $5.90 Million | ▲ +0.0 pp |
| 1992 | 100.0% | $3.40 Million | $0.00 | $3.50 Million | ▲ +0.0 pp |
| 1991 | 100.0% | $4.60 Million | $0.00 | $4.80 Million | — |